{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:38:33Z","timestamp":1773963513237,"version":"3.50.1"},"reference-count":22,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Department of Health\u2019s NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology"},{"name":"Novartis Pharmaceutical"},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["220558\/Z\/20\/Z"],"award-info":[{"award-number":["220558\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["MU4279\/2-1"],"award-info":[{"award-number":["MU4279\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,10]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To report the reduction in new neovascular age-related macular degeneration (nAMD) referrals during the COVID-19 pandemic and estimate the impact of delayed treatment on visual outcomes at 1\u2009year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective clinical audit and simulation model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Multiple UK National Health Service (NHS) ophthalmology centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Data on the reduction in new nAMD referrals were obtained from four NHS Trusts comparing April 2020 with April 2019. To estimate the potential impact on 1-year visual outcomes, a stratified bootstrap simulation model was developed drawing on an electronic medical records dataset of 20\u2009825 nAMD eyes from 27 NHS Trusts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Simulated mean visual acuity and proportions of eyes with vision \u22646\/60, \u22646\/24 and \u22656\/12 at 1\u2009year under four hypothetical scenarios: 0-month, 3-month, 6-month and 9-month treatment delays. Estimated additional number of eyes with vision \u22646\/60 at 1\u2009year nationally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of nAMD referrals dropped on average by 72% (range 65%\u201387%). Simulated 1-year visual outcomes for 1000 nAMD eyes with a 3-month treatment delay suggested an increase in the proportion of eyes with vision \u22646\/60 from 15.5% (13.2%\u201317.9%) to 23.3% (20.7%\u201325.9%), and a decrease in the proportion of eyes with vision \u22656\/12 (driving vision) from 35.1% (32.1%\u201338.1%) to 26.4% (23.8%\u201329.2%). Outcomes worsened incrementally with longer modelled delays. Assuming nAMD referrals are reduced to this level for 1\u2009month nationally, these simulated results suggest an additional 186\u2013365 eyes with vision \u22646\/60 at 1\u2009year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We report a large decrease in nAMD referrals during the COVID-19 lockdown and provide an important public health message regarding the risk of delayed treatment. As a conservative estimate, a treatment delay of 3 months could lead to a &gt;50% relative increase in the number of eyes with vision \u22646\/60 and 25%\u2009relative decrease in the number of eyes with driving vision at 1\u2009year.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-057269","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T11:32:17Z","timestamp":1650022337000},"page":"e057269","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model"],"prefix":"10.1136","volume":"12","author":[{"given":"Darren S","family":"Thomas","sequence":"first","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-2890","authenticated-orcid":false,"given":"Alasdair","family":"Warwick","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"},{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Olvera-Barrios","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Egan","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeshna","family":"Patra","sequence":"additional","affiliation":[{"name":"Ophthalmology, Barts Health NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralabos","family":"Eleftheriadis","sequence":"additional","affiliation":[{"name":"Ophthalmology, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-8585","authenticated-orcid":false,"given":"Anthony","family":"Khawaja","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Clinical and Experimental Sciences, University of Southampton, Southampton, UK"},{"name":"Southampton Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp L","family":"Muller","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Preston","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-2948","authenticated-orcid":false,"given":"Paul","family":"Taylor","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Tufail","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK"},{"name":"Institute of Ophthalmology, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"2025121422203741000_12.4.e057269.1","unstructured":"West D . Some hospitals left \u201cquiet\u201d as covid-19 sparks huge fall in attendances. Health Service Journal 2020."},{"key":"2025121422203741000_12.4.e057269.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043828"},{"key":"2025121422203741000_12.4.e057269.3","unstructured":"NHS Digital . Hospital outpatient activity 2018-19."},{"key":"2025121422203741000_12.4.e057269.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"2025121422203741000_12.4.e057269.5","unstructured":"European Centre for Disease Prevention and Control . Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU\/EEA and the UK \u2013 eighth update [Internet] 2020."},{"key":"2025121422203741000_12.4.e057269.6","unstructured":"Prime Minister\u2019s Office DS . PM statement on coronavirus: 16 March 2020;2020."},{"key":"2025121422203741000_12.4.e057269.7","unstructured":"Ophthalmologists RCo . Protecting patients, protecting staff 2020."},{"key":"2025121422203741000_12.4.e057269.8","unstructured":"Ophthalmologists. RCo . Reopening and redeveloping ophthalmology services during Covid recovery \u2013 interim guidance 2020."},{"key":"2025121422203741000_12.4.e057269.9","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2025121422203741000_12.4.e057269.10","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313682"},{"key":"2025121422203741000_12.4.e057269.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.031"},{"key":"2025121422203741000_12.4.e057269.12","unstructured":"UK DoHaSC . Certificate of vision impairment. explanatory notes for consultant ophthalmologists and hospital eye clinic staff in England 2017."},{"key":"2025121422203741000_12.4.e057269.13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/APO.0000000000000007","article-title":"Factors contributing to discrepancy between visual acuity fractions derived from a Snellen chart and letter scores on the early treatment diabetic retinopathy study chart","volume":"3","author":"Chen","year":"2014","journal-title":"Asia Pac J Ophthalmol"},{"key":"2025121422203741000_12.4.e057269.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2016.04.012","article-title":"Defining a minimum set of standardized patient-centered outcome measures for macular degeneration","volume":"168","author":"Rodrigues","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2025121422203741000_12.4.e057269.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"2025121422203741000_12.4.e057269.16","unstructured":"Team RC . R: a language and environment for statistical computing 2020."},{"key":"2025121422203741000_12.4.e057269.17","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301109"},{"key":"2025121422203741000_12.4.e057269.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011504"},{"key":"2025121422203741000_12.4.e057269.19","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30061-X"},{"key":"2025121422203741000_12.4.e057269.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.008"},{"key":"2025121422203741000_12.4.e057269.21","doi-asserted-by":"crossref","first-page":"e911","DOI":"10.1111\/aos.13751","article-title":"Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: post hoc analysis of the view studies","volume":"96","author":"Lanzetta","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"2025121422203741000_12.4.e057269.22","unstructured":"Ophthalmologists RCo . Medical retinal management plans during COVID-19 2020."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-057269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:20:45Z","timestamp":1765779645000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-057269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,15]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjopen-2021-057269"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-057269","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.02.20120642","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}